Correlation Between Faron Pharmaceuticals and Moonpig Group

Can any of the company-specific risk be diversified away by investing in both Faron Pharmaceuticals and Moonpig Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Faron Pharmaceuticals and Moonpig Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Faron Pharmaceuticals Oy and Moonpig Group PLC, you can compare the effects of market volatilities on Faron Pharmaceuticals and Moonpig Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Faron Pharmaceuticals with a short position of Moonpig Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Faron Pharmaceuticals and Moonpig Group.

Diversification Opportunities for Faron Pharmaceuticals and Moonpig Group

-0.51

Correlation Coefficient

Faron Pharmaceuticals  Moonpig Group

Excellent diversification

The 3 months correlation between Faron and Moonpig is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Faron Pharmaceuticals Oy and Moonpig Group PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moonpig Group PLC and Faron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Faron Pharmaceuticals Oy are associated (or correlated) with Moonpig Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moonpig Group PLC has no effect on the direction of Faron Pharmaceuticals i.e., Faron Pharmaceuticals and Moonpig Group go up and down completely randomly.

Pair Corralation between Faron Pharmaceuticals and Moonpig Group

Assuming the 90 days trading horizon Faron Pharmaceuticals Oy is expected to generate 1.59 times more return on investment than Moonpig Group. However, Faron Pharmaceuticals is 1.59 times more volatile than Moonpig Group PLC. It trades about 0.02 of its potential returns per unit of risk. Moonpig Group PLC is currently generating about 0.01 per unit of risk. If you would invest  20,500  in Faron Pharmaceuticals Oy on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Faron Pharmaceuticals Oy or generate 0.49% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Faron Pharmaceuticals Oy  vs.  Moonpig Group PLC

Faron Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Faron Pharmaceuticals Oy are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Faron Pharmaceuticals is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Moonpig Group PLC

Risk-Adjusted Performance

Very Weak

Over the last 90 days Moonpig Group PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Moonpig Group is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Faron Pharmaceuticals and Moonpig Group

The main advantage of trading using opposite Faron Pharmaceuticals and Moonpig Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Faron Pharmaceuticals position performs unexpectedly, Moonpig Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moonpig Group will offset losses from the drop in Moonpig Group's long position.

The idea behind Faron Pharmaceuticals Oy and Moonpig Group PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.